![(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C 5-g]quinazoline-2-thione dihydrochloride](https://cdn.shopify.com/s/files/1/0389/1897/9723/files/M34745_1743255696.gif?v=1743255696)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
5-g]quinazoline-2-thione dihydrochloride
A 1 mg dose of daclatasvir produced a mean 1
Formula: C36H34Cl2N2O7
It is used to induce genomic instability in mice and modification of the kinetics of growth of Gram-negative bacteria
) lower MAP over 24 hours in normotensive wild-type mice but not in KCa3
(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C 5-g]quinazoline-2-thione dihydrochloride( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver
US$ 2275.00
US$ 63.75
US$ 6750.00
US$ 6750.00
US$ 2950.00